Top compounds associated with response to LMLN


Feature Type Standardized
Nominal ANOVA
mRNA ciclosporin CTRPv2 pan-cancer AAC -0.013 0.7
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.012 0.7
mRNA ruxolitinib GDSC1000 pan-cancer AAC 0.012 0.7
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.012 0.7
mRNA alvocidib CTRPv2 pan-cancer AAC -0.017 0.7
mRNA MK-2206 CTRPv2 pan-cancer AAC -0.012 0.7
mRNA BRD-K11533227 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA BMS-708163 GDSC1000 pan-cancer AAC 0.012 0.7
mRNA ATRA CTRPv2 pan-cancer AAC -0.012 0.7
mRNA LE-135 CTRPv2 pan-cancer AAC -0.013 0.7
Download CSV